HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 2 December 2010

Recently publishes CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  16  papers were listed this time.  Here's a handful:

Meng Y, Ward S, Cooper K, et al.  Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.  Eur J Surg Oncol. 2010 Nov 27. [Epub ahead of print] PMID: 21115232

Chow IH, Tang CH, You SL, et al.  Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system. Br J Cancer. 2010 Nov 23. [Epub ahead of print] PMID: 21102588

Kozminski MA, Neumann PJ, Nadler ES, et al.  How Long and How Well: Oncologists' Attitudes Toward the Relative Value of Life-Prolonging v. Quality of Life-Enhancing Treatments.  Med Decis Making. 2010 Nov 18. [Epub ahead of print] PMID: 21088130

Baeten SA, van Exel NJ, Dirks M, et al.  Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach.  Cost Eff Resour Alloc. 2010 Nov 17;8(1):21. [Epub ahead of print] PMID: 21083901

Kondo M, Hoshi SL, Yamanaka T, et al.  Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03).  Breast Cancer Res Treat. 2010 Nov 17. [Epub ahead of print] PMID: 21082239